The composition and form of issue:
Chewable tablets, 1 tablet contains:
iron (III) hydroxide polymaltose
(equivalent to 100 mg iron)
folic acid 0.35 mg
excipients: dexterity macrogol 6000 purified talc sodium cyclamate, vanillin, cocoa powder, flavouring chocolate MKC
blister of 10 PCs the paper cartons 1, or 3 blisters.
Description pharmaceutical form:
Brown valium tablets with inclusions of white color, and scored.
Description pharmacological action:
The drug Maltofer Foul contains iron in the form polymaltose complex ferric hydroxide (III). This macromolecular complex is stable and does not emit iron in the form of free ions in the digestive tract. Structure Maltofer Foul similar to the natural compound of iron ferritin. Due to this similarity, iron (III) is transported from intestine to the blood by active transport. This property explains the inability of drug overdose in contrast to ordinary salts of iron, absorption of which takes place against a concentration gradient. The absorbed iron associated with the San and is stored in the body, mainly in the liver. Then in the bone marrow, it is included in the composition of hemoglobin. Iron, part polymaltose complex ferric hydroxide (III), does not possess prooxidant properties, unlike simple salts of iron. There is a correlation between the severity of iron deficiency and the level of its absorption (the more the severity of iron deficiency, the better suction). The most active absorption occurs in the duodenum and small intestine.
Folic acid — a b vitamin — stimulates erythropoiesis, participates in the synthesis of amino acids, nucleic acids, purines and pyrimidines, in the metabolism of choline.
Maltofer Foul in the pharmaceutical form chewable tablets does not cause staining of tooth enamel.
Application of pregnancy and breast-feeding:
In controlled studies in pregnant women in II and III trimesters of pregnancy was not observed undesirable effects of the drug on the mother and fetus. No data on adverse effects of the drug on the fetus during the first trimester of pregnancy.
Very rare (&ge0,001% and <0.01%) may experience signs of gastrointestinal irritation (a feeling of fullness, pressure in the epigastric region, nausea, constipation or diarrhea), and allergic reaction to folic acid.
Probably dark coloration of the stool due to the release of iron nevsosavsheysya (clinical significance has not).
Interaction with other medicinal products have not been identified.
Method of application and dose:
Inside, during or immediately after eating, chewing or swallowing whole.
The dosage and duration of therapy depend on the severity of iron deficiency. The daily dose can be taken 1 time a day.
Treatment clinically expressed iron deficiency (iron deficiency anemia): 1 table. 1-3 times a day for 3-5 months until normalization of hemoglobin level of blood. After that the drug should continue for a few more months in order to restore the iron stores in the body (1 table. a day).
Pregnant women should take 1 tab. Maltofer Foul 2-3 times a day until the normalization of hemoglobin. Then, therapy should be continued at a dosage of 1 table. a day, at least before the birth (to restore iron reserves).
For the treatment of latent iron deficiency and prevention of iron deficiency and folic acid patients should take 1 tab. of the drug a day.
The duration of treatment clinically expressed iron deficiency (iron deficiency anemia) is 3-5 months until normalization of hemoglobin level.
After that the drug should continue the dosage for the treatment of latent iron deficiency for several months, and for pregnant women, at least until the birth (to restore iron reserves).
The duration of treatment of latent iron deficiency is 1-2 months.
In case of clinically expressed iron deficiency, normalization of hemoglobin and replenishment of iron stores occurs only after 2-3 months after the start of treatment.
To date, cases of drug overdose were not reported no intoxication, no signs of iron overload.
One tablet Maltofer Foul contains 0.04 Yoo that must be considered when assigning patients with diabetes.
|The purpose of the medication||Hematotropics|